Your browser doesn't support javascript.
loading
Evaluation of the Abbott ARCHITECT HIV Ag/Ab combo assay for determining recent HIV-1 infection.
Curtis, Kelly A; Rudolph, Donna L; Pan, Yi; Delaney, Kevin; Anastos, Kathryn; DeHovitz, Jack; Kassaye, Seble G; Hanson, Carl V; French, Audrey L; Golub, Elizabeth; Adimora, Adaora A; Ofotokun, Igho; Bolivar, Hector; Kempf, Mirjam-Colette; Peters, Philip J; Switzer, William M.
Afiliação
  • Curtis KA; Division of HIV/ AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Rudolph DL; Division of HIV/ AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Pan Y; Division of HIV/ AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Delaney K; Division of HIV/ AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Anastos K; Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, United States of America.
  • DeHovitz J; Downstate Medical Center, State University of New York, Brooklyn, New York, United States of America.
  • Kassaye SG; Department of Medicine / Division of Infectious Diseases, Georgetown University, Washington, DC, United States of America.
  • Hanson CV; California State Department of Health, Berkeley, California, United States of America.
  • French AL; Department of Medicine, Stroger Hospital of Cook County, Chicago, Illinois, United States of America.
  • Golub E; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Adimora AA; Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Ofotokun I; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, United States of America.
  • Bolivar H; Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
  • Kempf MC; School of Nursing, Public Health and Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Peters PJ; Division of HIV/ AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Switzer WM; Division of HIV/ AIDS Prevention, National Center for HIV/AIDS, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS One ; 16(7): e0242641, 2021.
Article em En | MEDLINE | ID: mdl-34197451
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Antígenos HIV / Infecções por HIV Tipo de estudo: Evaluation_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Antígenos HIV / Infecções por HIV Tipo de estudo: Evaluation_studies / Guideline Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article